969652980	969652980	CD	B-NP	O
|	|	NN	I-NP	O
AMH	AMH	NN	I-NP	O
|	|	NN	I-NP	O
60849770	60849770	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
945418	945418	CD	B-NP	O
|	|	CC	I-NP	O
4/25/1997	4/25/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/5/1997	7/5/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/7/1997	10/7/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
DILATED	DILATED	VBN	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
MULTIPLE	MULTIPLE	NN	I-NP	O
INJURIES	INJURIES	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HISTORY	HISTORY	NN	I-NP	B-protein
OF	OF	IN	B-PP	I-protein
HEPATITIS	HEPATITIS	NNP	B-NP	O
B.	B.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42	42	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
functional	functional	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
transplant	transplant	NN	B-NP	O
work-up	work-up	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	I-NP	O
optimization	optimization	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
symptoms	symptom	NNS	B-NP	O
approximately	approximately	RB	B-NP	O
six	six	CD	I-NP	O
years	year	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
ultimately	ultimately	RB	I-ADVP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
clean	clean	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
''	''	''	O	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
included	include	VBD	B-VP	O
right	right	JJ	B-NP	O
hand	hand	NN	I-NP	O
and	and	CC	I-NP	O
face	face	NN	I-NP	O
anesthesia	anesthesia	NN	I-NP	O
and	and	CC	I-NP	O
hemiplegia	hemiplegia	NN	I-NP	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
seconds	second	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
self	self	PRP	B-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
end	end	NN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
diameter	diameter	NN	I-NP	O
of	of	IN	B-PP	O
6.2	6.2	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
fairly	fairly	RB	B-ADVP	O
well	well	RB	I-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
until	until	IN	B-PP	O
earlier	earlier	RBR	B-NP	O
this	this	DT	I-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
symptoms	symptom	NNS	B-NP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
illness	illness	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
probably	probably	RB	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
and	and	CC	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Atenolol	Atenolol	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
activities	activity	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
sledding	sledde	VBG	B-VP	O
and	and	CC	I-VP	O
skating	skate	VBG	I-VP	O
with	with	IN	B-PP	O
only	only	JJ	B-NP	O
occasional	occasional	JJ	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
11	11	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

Maximum	Maximum	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
148	148	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
rate	rate	NN	I-NP	B-protein
pressure	pressure	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
was	be	VBD	B-VP	O
18	18	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
peak	peak	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
consumption	consumption	NN	I-NP	O
was	be	VBD	B-VP	O
20.4	20.4	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
nitrates	nitrate	NNS	I-NP	O
were	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Atenolol	Atenolol	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
nitrates	nitrate	NNS	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
headache	headache	NN	B-NP	O
and	and	CC	I-NP	O
insomnia	insomnia	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
,	,	,	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
proceeding	proceed	VBG	B-VP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
worsening	worsen	VBG	I-VP	O
symptoms	symptom	NNS	B-NP	O
with	with	IN	B-PP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
exertion	exertion	NN	I-NP	O
with	with	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
appetite	appetite	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
amount	amount	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
fluid	fluid	NN	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
nocturnal	nocturnal	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Parker	Parker	NNP	I-NP	O
Willy	Willy	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
a	a	DT	B-NP	O
class	class	NN	I-NP	O
four	four	CD	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Thyna	Thyna	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Cuse	Cuse	NNP	B-NP	O
,	,	,	O	O
Nebraska	Nebraska	NNP	B-NP	O
41604	41604	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
for	for	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
orthopnea	orthopnea	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
four	four	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
nights	night	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
nocturia	nocturia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
anorexia	anorexia	NN	I-NP	O
without	without	IN	B-PP	O
vomiting	vomit	VBG	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
insomnia	insomnia	NN	B-NP	O
and	and	CC	I-NP	O
erectile	erectile	JJ	I-NP	O
difficulties	difficulty	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
6	6	CD	I-NP	O
lb	lb	NN	I-NP	O
.	.	.	O	O

weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
following	follow	VBG	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
diuretic	diuretic	JJ	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
175	175	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
165	165	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

and	and	CC	O	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
155	155	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
as	as	IN	B-PP	O
above	above	JJ	B-NP	O
,	,	,	I-NP	O
gunshot	gunshot	NN	I-NP	O
wound	wound	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
and	and	CC	I-NP	O
head	head	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
and	and	CC	I-NP	O
motor	motor	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
,	,	,	O	O
Hepatitis	Hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
four	four	CD	B-NP	O
colonoscopies	colonoscopy	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
polyps	polyp	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
appendectomy	appendectomy	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
ganglion	ganglion	NN	I-NP	O
cyst	cyst	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
wrist	wrist	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Enalapril	Enalapril	NNP	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	:	O	O
Atenolol	Atenolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Kay	Kay	NNP	I-NP	O
Ciel	Ciel	NNP	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Multivitamins	Multivitamin	NNPS	I-NP	O
one	one	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
sales	sale	NNS	I-NP	O
representative	representative	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
food	food	NN	I-NP	O
broker	broker	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
in	in	IN	B-PP	O
Y	Y	NN	B-NP	B-DNA
He	He	PRP	B-NP	I-DNA
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
who	who	WP	B-NP	O
quit	quit	VBD	B-VP	O
in	in	IN	B-PP	O
1984	1984	CD	B-NP	O
.	.	.	O	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
smoked	smoke	VBN	I-VP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
twelve	twelve	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	O	O
drinks	drink	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
six	six	CD	I-NP	O
beers	beer	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
father	father	NN	I-NP	O
is	be	VBZ	B-VP	O
70	70	CD	B-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
mother	mother	NN	I-NP	O
is	be	VBZ	B-VP	O
68	68	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sister	sister	NN	I-NP	O
with	with	IN	B-PP	O
colon	colon	NN	B-NP	O
polyps	polyp	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
brother	brother	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
healthy	healthy	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
notable	notable	JJ	I-ADJP	O
for	for	IN	B-PP	O
familial	familial	JJ	B-NP	O
colon	colon	NN	I-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	I-NP	O
polyposis	polyposis	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Weight	Weight	NN	B-NP	O
72	72	CD	B-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
afebrile	afebrile	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
95/71	95/71	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
normocephalic	normocephalic	JJ	B-ADJP	O
,	,	,	O	O
atraumatic	atraumatic	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
fillings	filling	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
neck	neck	NN	I-NP	O
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	NN	I-NP	O
,	,	,	O	O
carotid	carotid	NN	B-NP	O
bruits	bruit	NNS	I-NP	O
or	or	CC	O	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
distension	distension	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
impulse	impulse	NN	I-NP	O
palpable	palpable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
audible	audible	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
non-tender	non-tender	JJ	B-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
liver	liver	NN	I-NP	O
is	be	VBZ	B-VP	O
12-14	12-14	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
cm	cm	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
costal	costal	JJ	I-NP	O
margin	margin	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
right	right	JJ	I-NP	O
facial	facial	JJ	I-NP	O
asymmetry	asymmetry	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
neurological	neurological	JJ	I-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
non-focal	non-focal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Laboratory	Laboratory	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
133	133	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.2	1.2	CD	I-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
are	be	VBP	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
and	and	CC	I-NP	O
0.7	0.7	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
complete	complete	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
and	and	CC	I-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-VP	O
and	and	CC	O	O
an	an	DT	B-NP	O
FEV1/FVC	FEV1/FVC	NN	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
DLCO	DLCO	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
with	with	IN	B-PP	O
first	first	JJ	B-NP	O
degree	degree	NN	I-NP	O
atrioventricular	atrioventricular	JJ	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
PR	PR	NN	I-NP	B-protein
interval	interval	NN	I-NP	O
is	be	VBZ	B-VP	O
0.226	0.226	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
QRS	QRS	NN	I-NP	B-protein
interval	interval	NN	I-NP	O
is	be	VBZ	B-VP	O
0.10	0.10	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
QTC	QTC	NNP	I-NP	O
is	be	VBZ	B-VP	O
0.401	0.401	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
hemi-block	hemi-block	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
axis	axis	NN	I-NP	O
is	be	VBZ	B-VP	O
-49	-49	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
poor	poor	JJ	B-NP	O
R-wave	R-wave	NN	I-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
flipped	flip	VBN	I-VP	O
T-waves	T-wave	NNS	B-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
precordium	precordium	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
size	size	NN	I-NP	O
since	since	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-NP	O
no	no	DT	I-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42	42	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
idiopathic	idiopathic	JJ	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
now	now	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
functional	functional	JJ	B-NP	O
status	status	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
recent	recent	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
necessitating	necessitate	VBG	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
patient	patient	NN	B-NP	O
non-compliance	non-compliance	NN	I-NP	O
especially	especially	RB	B-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
which	which	WDT	B-NP	O
raises	raise	VBZ	B-VP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
psychologic	psychologic	JJ	B-NP	O
readiness	readiness	NN	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
55/12	55/12	CD	B-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
58/32	58/32	CD	B-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	O	O
arterial	arterial	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
113/74	113/74	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
Fick	Fick	NNP	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
2.85	2.85	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
1.49	1.49	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
venous	venous	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
280	280	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
systemic	systemic	JJ	I-NP	O
venous	venous	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
330	330	CD	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
this	this	DT	B-NP	O
markedly	markedly	RB	I-NP	O
high	high	JJ	I-NP	O
SVR	SVR	NN	I-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
borderline	borderline	JJ	I-NP	O
PVR	PVR	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
nitrates	nitrate	NNS	I-NP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Nitroprusside	Nitroprusside	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
SVR	SVR	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
PA	PA	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
enough	enough	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
pressures	pressure	NNS	I-NP	O
to	to	TO	B-VP	O
suggest	suggest	VB	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
successful	successful	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
candidate	candidate	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
nitrates	nitrate	NNS	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
intolerance	intolerance	NN	B-NP	O
to	to	TO	B-PP	O
nitrates	nitrate	NNS	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
headaches	headache	NNS	I-NP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-ADVP	O
all	all	DT	B-NP	O
nitrates	nitrate	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
managed	manage	VBN	I-VP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
Analopril	Analopril	NNP	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
pressure	pressure	NN	B-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Losartan	Losartan	NNP	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
afterload	afterload	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
without	without	IN	B-PP	O
orthostatic	orthostatic	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
increased	increase	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
quite	quite	RB	B-NP	O
a	a	DT	I-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
symptomatically	symptomatically	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
parts	part	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
work-up	work-up	NN	I-NP	O
were	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
including	include	VBG	B-PP	O
PPD	PPD	NN	B-NP	B-protein
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
either	either	CC	O	O
PPDs	PPD	NNS	B-NP	B-protein
or	or	CC	I-NP	O
controls	control	NNS	I-NP	O
at	at	IN	B-PP	O
72	72	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
B12	B12	NN	I-NP	B-protein
and	and	CC	O	O
folate	folate	VB	B-VP	O
level	level	NN	B-NP	O
drawn	drawn	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
thyroid	thyroid	JJ	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
Hepatitis	Hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
or	or	CC	I-NP	O
antibody	antibody	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Hepatitis	Hepatitis	NNP	B-NP	B-protein
C	C	NNP	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

24	24	CD	B-NP	O
hour	hour	NN	I-NP	O
urine	urine	NN	I-NP	O
collection	collection	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
clearance	clearance	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
88	88	CD	B-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	RB	I-VP	O
noted	note	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dental	Dental	NNP	B-NP	O
Consult	Consult	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
minor	minor	JJ	I-NP	O
restorative	restorative	JJ	I-NP	O
needs	need	NNS	I-NP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dentist	dentist	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
dentally	dentally	RB	I-VP	O
cleared	clear	VBN	I-VP	O
otherwise	otherwise	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
work-up	work-up	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
had	have	VBD	B-VP	O
become	become	VBN	I-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2	2	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
planned	plan	VBN	B-VP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
severely	severely	RB	B-NP	O
dilated	dilated	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
severe	severe	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
apical	apical	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
echo	echo	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
point	point	NN	I-NP	O
of	of	IN	B-PP	O
view	view	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Royce	Royce	NNP	I-NP	O
Mcumber	Mcumber	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Tho	Tho	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Captopril	Captopril	NNP	I-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Potassium	Potassium	NNP	I-NP	O
Slow	Slow	NNP	I-NP	O
Release	Release	NNP	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Lasix	Lasix	NNP	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Multivitamins	Multivitamin	NNPS	I-NP	O
one	one	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Losartan	Losartan	NNP	I-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
even	even	JJ	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
odd	odd	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LAMAR	LAMAR	NN	B-NP	B-protein
HOYSOCK	HOYSOCK	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KIP	KIP	NNP	B-NP	O
R.	R.	NNP	I-NP	O
MCCAMANT	MCCAMANT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WI	WI	NNP	I-NP	O
AP033/9930	AP033/9930	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
20003	20003	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

JIMX3I2QAG	JIMX3I2QAG	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/4/97	4/4/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/10/97	10/10/97	CD	B-NP	O

